NFKB1 and metabolic dysfunction-associated steatohepatitis: In a murine model of NASH, atorvastatin inhibited intestinal apical sodium-dependent bile salt transporter-mediated reabsorption of bile acids, stearoyl-coenzyme A desaturase-1 (key lipogenesis gene), and NF-kB signaling36.